Pharmaceutical Marketing: A Practical Guide

Pharmaceutical Marketing: A Practical Guide

Volumn , Issue , 2015, Pages 1-383

  Dogramatzis, Dimitris ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85179246853     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14416     Document Type: Book

References (40)

1. Abell, D. F. 1980. Defining the business: The starting point of strategic planning. Englewood Cliffs, N.J.: Prentice-Hall.
2. Ansoff, H. 1. 1957. Strategies for diversification. Harvard Business Review 35: 113-124.
3. Advantages of using pharmaceutical distribution intermediaries. 1999. National Wholesale Druggists' Association. www.Healthcare Distribution.org.
4. American Marketing Association. 1985. Marketing News March 1: 1.
5. American Marketing Association Committee on Definitions of Marketing Research. 1987. Chicago: AMA.
6. Assael, H. 1987. Consumer behavior and marketing action. 3d ed. Boston: Kent Publishing Company.
7. Borden, N. H. 1964. The concept of the marketing mix. Journal of Advertising Research June: 2-7.
8. Cooper, R. G., S. J. Edgett, and E. J. Kleinschmidt. 1998. Reading, MA: Perseus Books.
9. Council of Logistics Management. www.clml.org.
10. Drucker, P. F. 1993. Management: Tasks, responsibilities, practices. New York: Harperbusiness.
11. Editorial. 1994. Coalition charges FDA violated First Amendment. Medical Marketing Media 6.
12. Goodman Gilman, A., et al. 1990. The pharmacologic basis of therapeutics. 8th ed. Elmsford, N.Y.: Pergamon Press.
13. Forrester Research, Inc. www.forrester.com.
14. Henderson, B. D. 1973. The experience curve reviewed: The growth share market of the product portfolio. Perpectives No. 135. Boston, MA: The Boston Consulting Group.
15. IMS HEALTH and Comparative Media Reporting. www.IMSHealth.com
16. Industry Profile. Pharmaceutical Research and Manufacturers of America. 1999. Washington, D.C.: PhRMA.
17. Jenner, S. 2000. An overview of marketing careers. Maidenhead, UK: The Chartered Institute of Marketing.
18. Kaplan, R. S., and D. P. Norton. 1996. The balanced scorecard. Boston: Harvard Business School Press.
19. Kessler, D., and W. L. Pines. 1990. The Federal regulation of prescription drug adver- tising and promotion. JAMA 264: 2409-2415.
20. Kotler, P. 1980. Marketing management: Analysis, planning and control. 4th ed. Englewood Cliffs, N.J.: Prentice-Hall.
21. Kotler, P. 1991. Marketing management: Analysis, planning, and control. 7th ed. Englewood Cliffs, N.J.: Prentice Hall.
22. Kotler, P. and R. N. Clarke. 1987. Marketing for health care organizations. Englewood Cliffs, N.J.: Prentice Hall.
23. Maslow, A. H. 1954. Motivation and personality. London: Harper and Row.
24. Merck & Co. races ahead in sales league. 1999. SCRIP 2426/27:17.
25. Merck & Co. 1999. Mission and values statements. Merck & Co., Inc. www.Merck.com.
26. The Pharmaceutical industry in figures. 1999. Brussels: The European Federation of Pharmaceutical Industries and Associations (EFPIA).
27. Porter, M. E. 1979. Forces affecting competitive intensity. In How competitive forces shape strategy. Harvard Business Review 57(2): 137-145.
28. Porter, M. E. 1980. Competitive strategy: Techniques for analyzing industries and competition. N.Y.: The Free Press.
29. Porter, M. E. 1985. Competitive advantage. New York: The Free Press.
30. R&D as a percent of sales. 1999. Pharmaceutical Research and Manufacturers of America. Washington, D.C.: PhRMA.
31. Randall, T. 1991. Kennedy hearings say no more free lunch or much less-from drug firms. JAMA 265: 440-442.
32. Rausch, B. A. 1982. Strategic market planning. American Marketing Association.
33. Robinson, P. J., et al. 1967. Industrial buying and creative marketing. Boston: Allyn & Bacon.
34. Rogers, E. M. 1976. New product adoption and diffusion. Journal of Consumer Research 2: 290-301.
35. Schering-Plough Corporation. 1999. Mission and values statements. Schering-Plough Corporation. www.sgp.com.
36. Schramm, W. 1954. How communication works. In The process and effects of mass communication. W. Schramm, ed. Urbana, Ill.: The University of Illinois Press.
37. Terms of reference. 1990. International Conference on Harmonization.
38. U.S. Senate. 1990. Committee on Labor and Human Resources. Examining practices of United States pharmaceutical companies and how drug prices and prescriptions are affected: Hearing before the Committee on Labor and Human Resources. 101st Cong., 2nd sess. 11 and 12 December.
39. Wright, R. V. L. 1974. A system for managing diversity. Cambridge, Mass.: Arthur D. Little.
40. Zikmund, W. G., and M. D'Amico, eds. 1996. Marketing, 5th ed. St. Paul, Minn.: West Publishing Company.